293 related articles for article (PubMed ID: 9311628)
1. Metabolic disposition of the new fluoroquinolone antibacterial agent DW116 in rats.
Park YH; Jung BH; Chung BC; Park J; Mitoma C
Drug Metab Dispos; 1997 Sep; 25(9):1101-3. PubMed ID: 9311628
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and excretion study of DW116, a new fluoroquinolone, in rats.
Jung BH; Park YH; Park J; Chung BC
Arch Pharm Res; 1997 Aug; 20(4):358-62. PubMed ID: 18975179
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
5. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
[TBL] [Abstract][Full Text] [Related]
7. The disposition of gemifloxacin, a new fluoroquinolone antibiotic, in rats and dogs.
Ramji JV; Austin NE; Boyle GW; Chalker MH; Duncan G; Fairless AJ; Hollis FJ; McDonnell DF; Musick TJ; Shardlow PC
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):435-42. PubMed ID: 11259328
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the new fluoroquinolone balofloxacin in mice, rats, and dogs.
Nakagawa T; Ishigai M; Kato M; Hayakawa N; Kinoshita H; Okutomi T; Ohkubo K; Okazaki A
Arzneimittelforschung; 1995 Jun; 45(6):719-22. PubMed ID: 7646579
[TBL] [Abstract][Full Text] [Related]
9. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and urinary excretion of DW116, a new fluoroquinolone antibacterial agent, in humans as a phase I study.
Jung BH; Choi MH; Chung BC
Drug Dev Ind Pharm; 2000 Jan; 26(1):103-6. PubMed ID: 10677817
[TBL] [Abstract][Full Text] [Related]
11. Disposition of [14C]avitriptan in rats and humans.
Marathe PH; Greene DS; Barbhaiya RH
Drug Metab Dispos; 1997 Jul; 25(7):881-8. PubMed ID: 9224783
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
13. Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys.
Vincent SH; Painter SK; Luffer-Atlas D; Karanam BV; McGowan E; Cioffe C; Doss G; Chiu SH
Drug Metab Dispos; 1997 Aug; 25(8):932-9. PubMed ID: 9280401
[TBL] [Abstract][Full Text] [Related]
14. Disposition of a new antiinfective agent 1,3-di(4-imidazolino-2-methoxyphenoxy)propane in male rats.
Bekersky I; Puhl RJ; Hanson G; Mong S
Drug Metab Dispos; 1993; 21(6):1017-21. PubMed ID: 7905379
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
[TBL] [Abstract][Full Text] [Related]
16. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP
Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
[TBL] [Abstract][Full Text] [Related]
18. Hepatobiliary transport kinetics of HSR-903, a new quinolone antibacterial agent.
Murata M; Tamai I; Sai Y; Nagata O; Kato H; Sugiyama Y; Tsuji A
Drug Metab Dispos; 1998 Nov; 26(11):1113-9. PubMed ID: 9806954
[TBL] [Abstract][Full Text] [Related]
19. The disposition and pharmacokinetics of alpidem, a new anxiolytic, in the rat.
Garrigou-Gadenne D; Durand A; Thenot JP; Morselli PL
Drug Metab Dispos; 1991; 19(3):574-9. PubMed ID: 1680622
[TBL] [Abstract][Full Text] [Related]
20. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
Colletti AE; Krieter PA
Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]